Swiss biotech sector continues to thrive

Published: 8-May-2007
Ingredients Pharmaceutical

Swiss Biotech, the biotech consortium of Switzerland, has released its annual report 2007, which shows that Switzerland is a thriving location for biotech and life sciences with excellent conditions for business, investments, IPOs, and r&d in the sector.


Swiss Biotech, the biotech consortium of Switzerland, has released its annual report 2007, which shows that Switzerland is a thriving location for biotech and life sciences with excellent conditions for business, investments, IPOs, and r&d in the sector.

The Swiss Biotech Report 2007 reveals that industry turnover for 2006 was CHF6.424bn (Euro 6.894bn), 7.8% higher than in 2005 (CHF5.961bn; €3.613bn). The r&d spend by private and listed companies was CHF1.6bn (€0.97 bn), a rise of 4.4% on the previous year (CHF1.533bn; €0.97bn).

Swiss Biotech represents currently 218 Swiss biotech companies, employing some 15,000 people. The companies are divided into 79 core biotech developer companies and 58 extended biotech developer companies, as well as 81 biotech suppliers, excluding multinational pharma subsidiaries. Together these companies achieved a combined profit of CHF917m (€556m).

Of the 137 Swiss biotech development companies, 85% are active in so-called 'red' biotechnology (human and veterinary medicine), 7% in environmental and industry processes ('white' biotechnology) and 8% in agriculture and food ('green' biotechnology).

Various biotech and pharma start-ups listed on the SWX Swiss Exchange showed impressive overall growth: Actelion, well on its way towards its first billion CHF in annual sales, achieved 151%; Cytos grew 132%; and Arpida registered a strong result of +93% after a slow start. Basilea (+53%) and Speedel (+18%) also exceeded the Swiss Market Index of +16%.

See more

You may also like

Packaging

ProMach Pharma presents new equipment at Pack Expo Las Vegas

Read more
Several new systems will be on exhibit for the first time, alongside other advanced processing and packaging equipment for pharmaceuticals, biopharmaceuticals, nutraceuticals, medical devices and more

Trending Articles

  1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
  2. ProMach Pharma presents new equipment at Pack Expo Las Vegas Several new systems will be on exhibit for the first time, alongside other advanced processing and packaging equipment for pharmaceuticals, biopharmaceuticals, nutraceuticals, medical devices and more
  3. Bavarian Nordic launches chikungunya vaccine Vimkunya in the UK The UK announcement of the recombinant vaccine follows recent approval by the MHRA in May 2025
  4. FDA makes groundbreaking decision to waive clinical efficiency studies for monoclonal antibody biosimilars The University of Illinois secured the first-ever FDA acceptance to waive clinical efficiency studies (CESs) for the biological drugs
  5. CPHI Frankfurt 2025 to welcome more than 60,000 pharma professionals with expanded focus on innovation and sustainability Returning to Germany from 28-30 October, CPHI Frankfurt 2025 will unite the global pharmaceutical supply chain with more than 2000 exhibitors, six content theatres and new feature zones

Upcoming event

Enhancing probiotic stability through smarter formulation and packaging strategies

18 September 2025 | Virtual See all

You may also like

Packaging

ProMach Pharma presents new equipment at Pack Expo Las Vegas

Several new systems will be on exhibit for the first time, alongside other advanced processing and packaging equipment for pharmaceuticals, biopharmaceuticals, nutraceuticals, medical devices and more
Pharmaceutical

CPHI Frankfurt 2025 to welcome more than 60,000 pharma professionals with expanded focus on innovation and sustainability

Returning to Germany from 28-30 October, CPHI Frankfurt 2025 will unite the global pharmaceutical supply chain with more than 2000 exhibitors, six content theatres and new feature zones
Manufacturing

Continuous innovation: redefining the future of pharmaceutical manufacturing

In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
Pharmaceutical

Keystone Folding Box Co. unveils Key-Pak Plus

Designed to protect children and empower seniors, it achieves top U.S. safety ratings and meets global accessibility standards
Pharmaceutical

Bavarian Nordic launches chikungunya vaccine Vimkunya in the UK

The UK announcement of the recombinant vaccine follows recent approval by the MHRA in May 2025
Research & Development

Servier and IDEAYA Biosciences join forces to bring a promising new eye cancer treatment to patients across the globe

Servier and IDEAYA Biosciences have entered into an exclusive license agreement for regulatory and commercial rights to darovasertib outside the US
Pharmaceutical

Atelerix and Rodon Global enter new partnership to create cryo-free logistics

The initial agreement will be to incorporate Atelerix’s non-cryogenic cell preservation technology into Rodon's international freight and logistics services for drug discovery and clinical trials
Subscribe now